Harrison Ian, Takeuchi Yasuhiro, Bartosch Birke, Stoye Jonathan P
National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.
J Virol. 2004 Dec;78(24):13871-9. doi: 10.1128/JVI.78.24.13871-13879.2004.
Porcine endogenous retroviruses (PERVs) pose a potential stumbling block for therapeutic xenotransplantation, with the greatest threat coming from viruses generated by recombination between members of the PERV subgroup A (PERV-A) and PERV-C families (PERV-A/C recombinants). PERV-A and PERV-B have been shown to infect human cells in culture, albeit with low titers. PERV-C has a more restricted host range and cannot infect human cells. A recombinant PERV-A/C virus (PERV-A14/220) contains the PERV-A sequence between the end of pol and the middle of the SU region in env. The remaining sequence is derived from PERV-C. PERV-A14/220 is approximately 500-fold more infectious than PERV-A. To determine the molecular basis for the increased infectivity of PERV-A14/220, we have made a series of vector constructs. The primary determinant for the enhanced replicative potential of the recombinant virus appeared to be the env gene. Using a series of chimeric env genes, we could identify two determinants of high infectivity; one was an isoleucine to valine substitution at position 140 between variable regions A and B, and the other lies within the proline rich region. Taken together, these results show that the novel juxtaposition of env gene sequences enhanced the infectivity of PERV-A14/220 for human cells, perhaps by stabilization of the envelope glycoprotein or increased receptor binding.
猪内源性逆转录病毒(PERVs)是治疗性异种移植的潜在绊脚石,最大的威胁来自PERV亚组A(PERV-A)和PERV-C家族成员之间重组产生的病毒(PERV-A/C重组体)。PERV-A和PERV-B已被证明能在培养物中感染人类细胞,尽管滴度较低。PERV-C的宿主范围更窄,不能感染人类细胞。重组PERV-A/C病毒(PERV-A14/220)在env中pol末端和SU区域中部之间包含PERV-A序列。其余序列来自PERV-C。PERV-A14/220的感染性比PERV-A高约500倍。为了确定PERV-A14/220感染性增加的分子基础,我们构建了一系列载体构建体。重组病毒复制潜力增强的主要决定因素似乎是env基因。使用一系列嵌合env基因,我们可以确定两个高感染性决定因素;一个是可变区A和B之间第140位的异亮氨酸到缬氨酸的取代,另一个位于富含脯氨酸的区域内。综上所述,这些结果表明,env基因序列的新并列增强了PERV-A14/220对人类细胞的感染性,可能是通过包膜糖蛋白的稳定或受体结合增加实现的。